NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Tolerability


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Findings from S. Berning and co-authors provide new insights into epilepsy
2009 NOV 23 ... onset and duration of SE, dose of LEV, concurrent antiepileptic drugs (AED) treatment, tolerability, and outcome. Thirty-two patients (15 female) were found who were treated with i.v. LEV ...
Subject: Epilepsy
Price: $3.00
*
Labopharm's novel trazodone formulation subject of publication in peer-reviewed medical journal
2009 NOV 23 ... hypnotic, a new controlled release formulation that has the potential to improve the tolerability of high doses may provide an opportunity to revisit this multifunctional drug as an ...
Subject: Anxiety Disorders
Price: $3.00
*
Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome
2009 NOV 23 ... four-week, randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of LX1031 and its effects on symptoms associated with IBS. The study included 155 ...
Subject: Irritable Bowel Syndrome
Price: $3.00
*
Mithridion Announces Progress With Drugs for Alzheimer's Disease and Schizophrenia
2009 NOV 23 ... in late 2008, as previously announced. The company plans to evaluate the safety, tolerability and pharmacokinetics of MCD-386CR in a randomized, double-blind, placebo-controlled, ...
Subject: Alzheimer Disease
Price: $3.00
*
Neurogen Corporation Announces Third Quarter 2009 Financial Results and Updates Operations
2009 NOV 25 ... indications of efficacy in the RLS study of aplindore, our analysis of both efficacy and tolerability - when considered in the context of observations from similar clinical studies with ...
Subject: Neurogen Corporation
Price: $3.00
*
New findings from A.O. Doesch and co-authors describe advances in heart transplants
2009 NOV 23 ... channel antagonist ivabradine on heart rate control, effects on left ventricular mass, tolerability, and safety are available in patients after heart transplantation (HTX)." ...
Subject: Heart Transplants
Price: $3.00
*
New pharmacological research from University of Liege discussed
2009 NOV 23 ... that the use of COX-2 selective or preferential inhibitors is associated with a better tolerability opened new horizons in the search of safer drugs for the management of inflammation," ...
Subject: Pharmacological
Price: $3.00
*
Novavax Begins Phase IIa Study of Seasonal Influenza Vaccine in Older Adults
2009 NOV 23 ... older. This randomized, double-blind, active-controlled study is evaluating the safety, tolerability and immunogenicity of two different doses of Novavax's trivalent seasonal influenza VLP ...
Subject: Flu Vaccines
Price: $3.00
*
PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain
2009 NOV 23 ... Cox-2 inhibitors, opioids, and other analgesics that are dosed daily and have various tolerability and safety issues, including the potential for abuse and addiction. If the Phase 1 trial ...
Subject: PanGenetics
Price: $3.00
*
QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuoCR
2009 NOV 23 ... of acute pain. Study results consistently demonstrate MoxDuo™IR's greater overall tolerability, achieving better pain r! elief with substantially fewer incidences of ...
Subject: Biotech Business
Price: $3.00
*
Reports from T. Ciuleanu and colleagues advance knowledge in non-small cell lung cancer
2009 NOV 23 ... According to a study from the United States, "Several studies have shown the efficacy, tolerability, and ease of administration of pemetrexed-an antifolate antineoplastic agent-in patients ...
Subject: Non-Small Cell Lung Cancer
Price: $3.00
*
Research in the area of pediatrics reported from Bristol-Myers Squibb Company
2009 NOV 28 ... and the clinician-rated Clinical Global Impressions-improvement score. Safety and tolerability were also assessed. At week 8, all aripiprazole doses produced significantly greater ...
Subject: Pediatrics
Price: $3.00
*
Research in the area of sclerosis reported from University of Michigan
2009 NOV 23 ... effective therapies are lacking. The study was designed to assess the safety, tolerability, and efficacy of tadalafil, a selective, long acting, type V cyclic GMP ...
Subject: Sclerosis
Price: $3.00
*
Research results from Brigham and Women's Hospital update understanding of life sciences
2009 NOV 23 ... have not been noted in studies of anacetrapib to date. Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib (DEFINE) is a randomized, double-blind, ...
Subject: Life Sciences
Price: $3.00
*
Researchers at Hamdard University have published new data on typhoid fever
2009 NOV 23 ... typhoid fever are available, improvements are desired in dosage, immunogenicity and tolerability. Emergent BioSolutions Inc is developing M-01ZH09, a single-dose oral vaccine against ...
Subject: Typhoid Fever
Price: $3.00
*
Researchers from University of Maryland discuss findings in diabetes
2009 NOV 23 ... systolic blood pressure reduction can be achieved with excellent safety and good tolerability in patients with type 2 diabetes mellitus." Weir and colleagues published ...
Subject: Diabetes
Price: $3.00
*
Scientists at University of Colorado publish research in arthritis
2009 NOV 23 ... study, researchers in the United States conducted a study "To assess the safety, tolerability and efficacy of abatacept in patients with rheumatoid arthritis ( RA) who had failed ...
Subject: Arthritis
Price: $3.00
*
Studies from University Medical Center add new findings in the area of schizophrenia quality of care
2009 NOV 23 ... with first-generation antipsychotics (FGAs), with most finding better efficacy and tolerability for SGAs. However, these 'efficacy trials' were generally short term and included only ...
Subject: Schizophrenia Quality of Care
Price: $3.00
*
Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference
2009 NOV 23 ... dose (MAD) study, were undertaken to assess the pharmacokinetics, safety and tolerability of TBR-652 in two tablet formulations under fasted and fed conditions, respectively. In ...
Subject: Pharmacokinetics
Price: $3.00
*
Winston Pharmaceuticals, Inc. to Present at Lazard Capital Markets 6th Annual Healthcare Conference
2009 NOV 23 ... significant unmet needs for pain management options with improved efficacy, safety, and tolerability profiles. Winston's product candidates span a range of pain indications, including ...
Subject: Winston Pharmaceuticals, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login